Consonance Capital Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,566,054
Closed -$37.1M 33
2020
Q1
$37.1M Buy
3,566,054
+579,668
+19% +$7.38M 2.76% 15
2019
Q4
$53.4M Buy
+2,986,386
New +$44.1M 3.26% 13
2016
Q3
Sell
-526,351
Closed -$3.62M 25
2016
Q2
$3.62M Buy
526,351
+120,000
+30% +$679K 0.51% 19
2016
Q1
$2.18M Hold
406,351
0.33% 18
2015
Q4
$2.03M Buy
406,351
+181,951
+81% +$899K 0.27% 18
2015
Q3
$925K Buy
+224,400
New +$899K 0.13% 27

Other funds holding AXGN

Consonance Capital Management's AXGN Position: Q2 2020 in Review

Consonance Capital Management sold out of Axogen (AXGN) in Q2 2020, closing a stake of 3,566,054 shares — an estimated $37.1M sold.

Consonance Capital Management first reported a position in AXGN in Q3 2015 and held it in 6 quarters. The position peaked at $53.4M in Q4 2019. 114 funds tracked by Wall St. Rank hold AXGN as of Q2 2020.

  • Consonance Capital Management reported no remaining Axogen position as of Q2 2020 after selling out during the quarter.
  • Consonance Capital Management sold 3,566,054 Axogen shares in Q2 2020, an estimated $37.1M.
  • Consonance Capital Management first reported a position in Axogen in Q3 2015 and held it in 6 quarters.
  • Consonance Capital Management's Axogen position peaked at $53.4M in Q4 2019.
  • 114 funds tracked by Wall St. Rank held Axogen as of Q2 2020.

Based on Consonance Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.